Bayer CropScience Limited posted a strong start to FY 2025-26, reporting a 17 per cent year-on-year rise in Revenue from Operations to Rs 19,146 million for the quarter ended June 30, 2025, up from Rs 16,314 million in the same period last year. Profit Before Tax climbed to Rs 3,352 million, compared to Rs 3,158 million in Q1 FY 2024-25, while Profit After Tax advanced 10 per cent on the back of robust sales momentum and easing input cost pressures.

The quarter’s performance was powered by higher volumes in Corn seeds and the herbicide Roundup, aided by the early onset of the monsoon. The company also rolled out BICOTA, a new innovation targeting Stem Borer management in paddy—a key intervention aimed at strengthening productivity for India’s smallholder farmers.

“In Q1, BCSL achieved 17 per cent growth in Revenue from Operations, primarily driven by higher volumes of Corn seeds and Roundup supported by the early onset of the monsoon. Additionally, we successfully launched BICOTA to help farmers nationwide manage Stem Borers in paddy,” said Simon Wiebusch, Vice Chairman, Managing Director & CEO, Bayer CropScience Limited.

“We delivered a 10 per cent increase in Profit After Tax for the quarter, underpinned by strong sales growth and early signs of input cost stabilization. While operating expenses were elevated due to the early monsoon, our focus on cost discipline positions us well for sustained performance,” added Vinit Jindal, Executive Director & CFO.

With India’s kharif season off to a strong start and a diversified product portfolio spanning seeds, crop protection, and farmer advisory services, Bayer CropScience enters the rest of FY 2025-26 with an eye on scaling innovation-led growth while maintaining operational discipline.